{{Taxobox
| color = khaki
| image = Trichomonas vaginalis phase contrast microscopy.jpg
| image_width = 240px
| image_caption = ''T. vaginalis'' [[phase contrast microscopy]]
| domain = [[Eukarya]]
| kingdom = [[Excavata]]
| phylum = [[Metamonada]]
| classis = [[Parabasalia]]
| ordo = [[Trichomonadida]]
| genus = ''[[Trichomonas]]''
| species = '''''T. vaginalis'''''
| binomial = ''Trichomonas vaginalis''
| binomial_authority = ([[Alfred François Donné|Donné]] 1836)
}}'''''Trichomonas vaginalis''''' is an [[Anaerobic organism|anaerobic]], [[flagellate]]d [[protozoan]], a form of [[microorganism]]. The [[parasite|parasitic]] microorganism is the causative agent of [[trichomoniasis]], and is the most common [[pathogen]]ic protozoan infection of humans in industrialized countries.<ref name=Soper_2004>{{cite journal |last1=Soper |first1=D |title=Trichomoniasis: under control or undercontrolled? |journal=American Journal of Obstetrics and Gynecology |volume=190 |issue=1 |pages=281–90 |year=2004 |pmid=14749674 |doi=10.1016/j.ajog.2003.08.023}}</ref> Infection rates between men and women are the same with women showing symptoms while infections in men are usually asymptomatic. Transmission takes place directly because the [[trophozoite]] does not have a [[cyst]]. The [[WHO]] has estimated that 160 million cases of infection are acquired annually worldwide.<ref name="pmid21440359"/> The estimates for [[North America]] alone are between 5 and 8 million new infections each year, with an estimated rate of [[asymptomatic]] cases as high as 50%.<ref name=Hook_1999>{{cite journal |last1=Hook |first1=Edward W. |title=''Trichomonas vaginalis''—No Longer a Minor STD |journal=Sexually Transmitted Diseases |volume=26 |issue=7 |pages=388–9 |year=1999 |pmid=10458631 |doi=10.1097/00007435-199908000-00004}}</ref> Usually treatment consists of [[metronidazole]] and [[tinidazole]].<ref>{{cite web |url=http://www.thesticlinic.com/trichomonas-vaginalis.aspx |publisher=Online Medical Services Limited |title=''Trichomonas Vaginalis''}}{{Unreliable medical source|date=January 2011}}</ref>

==Clinical==

===Mechanism of infection===
''Trichomonas vaginalis'', a parasitic protozoan, is the etiologic agent of trichomoniasis, and is a [[sexually transmitted infection]].<ref name="pmid21440359"/><ref name="pmid18192787">{{cite journal |author=Johnston VJ, Mabey DC |title=Global epidemiology and control of Trichomonas vaginalis |journal=Current Opinion in Infectious Diseases |volume=21 |issue=1 |pages=56–64 |year=2008 |month=February |pmid=18192787 |doi=10.1097/QCO.0b013e3282f3d999}}</ref> More than 160 million people worldwide are annually infected by this protozoan.<ref name="pmid21440359">{{cite journal |pages=3–9 |doi=10.1016/j.ejogrb.2011.02.024 |title=Trichomoniasis: Evaluation to execution |year=2011 |last1=Harp |first1=Djana F. |last2=Chowdhury |first2=Indrajit |journal=European Journal of Obstetrics & Gynecology and Reproductive Biology |volume=157 |pmid=21440359 |issue=1}}</ref>

===Symptoms===
[[Image:Pap test trichomonas.JPG|thumb|right|Pap smear, showing infestation by ''Trichomonas vaginalis''. [[Papanicolaou stain]], 400x.]] [[Trichomoniasis]], a sexually transmitted infection of the [[Genitourinary system|urogenital tract]], is a common cause of [[vaginitis]] in women, while men with this infection can display symptoms of [[urethritis]]. 'Frothy', malodorous, greenish vaginal discharge is characteristic.<ref name="Pmid">{{cite journal |pmid=16441214 |year=2006 |last1=Nanda |first1=N |last2=Michel |first2=RG |last3=Kurdgelashvili |first3=G |last4=Wendel |first4=KA |title=Trichomoniasis and its treatment |volume=4 |issue=1 |pages=125–35 |doi=10.1586/14787210.4.1.125 |journal=Expert review of anti-infective therapy}}</ref>

===Signs===
20% of women with the infection will have a "strawberry" cervix (''colpitis macularis'', an erythematous cervix with punctate areas of exudation) or vagina on examination.<ref>{{cite journal |author=Swygard H, Seña AC, Hobbs MM, Cohen MS |title=Trichomoniasis: clinical manifestations, diagnosis and management |journal=Sex Transm Infect |volume=80 |issue=2 |pages=91–5 |year=2004 |month=April |pmid=15054166 |pmc=1744792 |url=http://sti.bmj.com/cgi/pmidlookup?view=long&pmid=15054166 |doi=10.1136/sti.2003.005124}}</ref><ref>{{cite journal |author=Petrin D, Delgaty K, Bhatt R, Garber G |title=Clinical and microbiological aspects of ''Trichomonas vaginalis'' |journal=Clin. Microbiol. Rev. |volume=11 |issue=2 |pages=300–17 |year=1998 |month=April |pmid=9564565 |pmc=106834 |url=http://cmr.asm.org/cgi/pmidlookup?view=long&pmid=9564565}}</ref><ref>{{cite journal |author=Garber GE |title=The laboratory diagnosis of ''Trichomonas vaginalis'' |journal=Can J Infect Dis Med Microbiol |volume=16 |issue=1 |pages=35–8 |year=2005 |month=January |pmid=18159526 |pmc=2095007 }}</ref> This is due to capillary dilation as a result of the inflammatory response.

===Complications===
Some of the complications of ''T. vaginalis'' in women include: [[Premature birth|preterm delivery]], low birth weight, and increased mortality as well as predisposing to [[HIV]] infection, [[AIDS]], and [[cervical cancer]].<ref name=Schwebke_2004>{{cite journal |last1=Schwebke |first1=J. R. |last2=Burgess |first2=D. |title=Trichomoniasis |journal=Clinical Microbiology Reviews |volume=17 |issue=4 |pages=794–803, table of contents |year=2004 |doi=10.1128/CMR.17.4.794-803.2004 |pmid=15489349 |pmc=523559}}</ref> ''T. vaginalis'' has also been reported in the [[Urinary system|urinary tract]], [[fallopian tube]]s, and pelvis and can cause [[pneumonia]], [[bronchitis]], and oral lesions. [[Condom]]s are effective at reducing, but not wholly preventing, transmission.<ref name=CDCfactsheet>{{cite web |url=http://www.cdc.gov/std/trichomonas/stdfact-trichomoniasis.htm |title=Trichomoniasis |work=CDC Fact Sheet |date=2007-12-17 |publisher=Centers for Disease Control and Prevention |accessdate=2010-06-11}}</ref> 

Recent research also suggests a link between ''T. vaginalis'' infection in males and subsequent aggressive prostate cancer.<ref name=pmid19741211>{{cite journal |last1=Stark |first1=Jennifer R. |last2=Judson |first2=Gregory |last3=Alderete |first3=John F. |last4=Mundodi |first4=Vasanthakrishna |last5=Kucknoor |first5=Ashwini S. |last6=Giovannucci |first6=Edward L. |last7=Platz |first7=Elizabeth A. |last8=Sutcliffe |first8=Siobhan |last9=Fall |first9=Katja |title=Prospective Study of ''Trichomonas vaginalis'' Infection and Prostate Cancer Incidence and Mortality: Physicians' Health Study |journal=JNCI Journal of the National Cancer Institute |volume=101 |issue=20 |pages=1406–11 |year=2009 |doi=10.1093/jnci/djp306 |pmid=19741211 |pmc=2765259}}</ref>

===Diagnosis===
Classically, with a [[Pap test|cervical smear]], infected women have a transparent "halo" around their superficial cell nucleus. It is unreliably detected by studying a genital discharge or with a cervical smear because of their low [[sensitivity (tests)|sensitivity]]. ''T. vaginalis'' was traditionally diagnosed via a wet mount, in which "corkscrew" motility was observed. Currently, the most common method of diagnosis is via overnight culture,<ref name=Ohlermeyer_1998>{{cite journal |last1=Ohlemeyer |first1=C |last2=Hornberger |first2=L |last3=Lynch |first3=D |last4=Swierkosz |first4=E |title=Diagnosis of ''Trichomonas vaginalis'' in adolescent females: InPouch TV® culture versus wet-mount microscopy |journal=Journal of Adolescent Health |volume=22 |issue=3 |pages=205–8 |year=1998 |month=March |pmid=9502007 |doi=10.1016/S1054-139X(97)00214-0}}</ref><ref name=Sood_2007>{{cite journal |first1=Seema |last1=Sood |first2=Srujana |last2=Mohanty |first3=Arti |last3=Kapil |first4=Jorge |last4=Tolosa |first5=Suneeta |last5=Mittal |title=InPouch TV culture for detection of ''Trichomonas vaginalis'' |pmid=17598943 |year=2007 |pages=567–71 |issue=4 |volume=125 |journal=The Indian journal of medical research |url=http://www.icmr.nic.in/ijmr/2007/April/0410.pdf}}</ref> with a sensitivity range of 75-95%.<ref name=pmid17578778>{{cite journal |last1=Huppert |first1=Jill S. |last2=Mortensen |first2=Joel E. |last3=Reed |first3=Jennifer L. |last4=Kahn |first4=Jessica A. |last5=Rich |first5=Kimberly D. |last6=Miller |first6=William C. |last7=Hobbs |first7=Marcia M. |title=Rapid Antigen Testing Compares Favorably with Transcription‐Mediated Amplification Assay for the Detection of ''Trichomonas vaginalis'' in Young Women |journal=Clinical Infectious Diseases |volume=45 |issue=2 |pages=194–8 |year=2007 |pmid=17578778 |doi=10.1086/518851}}</ref> Newer methods, such as [[rapid strep test|rapid antigen test]]ing and [[transcription-mediated amplification]], have even greater sensitivity, but are not in widespread use.<ref name=pmid17578778/> The presence of ''T. vaginalis'' can also be diagnosed by [[polymerase chain reaction|PCR]], using primers specific for GENBANK/L23861.<ref name=Schirm_2007>{{cite journal |last1=Schirm |first1=Jurjen |last2=Bos |first2=Petra A.J. |last3=Roozeboom-Roelfsema |first3=Irene K. |last4=Luijt |first4=Dirk S. |last5=Möller |first5=Lieke V. |title=''Trichomonas vaginalis'' detection using real-time TaqMan PCR |journal=Journal of Microbiological Methods |volume=68 |issue=2 |pages=243–7 |year=2007 |pmid=17005275 |doi=10.1016/j.mimet.2006.08.002}}<br/>{{cite web |title=''Trichomonas vaginalis'' repeated DNA target for PCR identification |id=L23861.1 |work=GenBank Nucleotide Database |publisher=National Center for Biotechnology Information |url=http://www.ncbi.nlm.nih.gov/nuccore/496275}}<br/>{{cite journal |author=Kengne P, Veas F, Vidal N, Rey JL, Cuny G |title=''Trichomonas vaginalis'': repeated DNA target for highly sensitive and specific polymerase chain reaction diagnosis |journal=Cell. Mol. Biol. (Noisy-le-grand) |volume=40 |issue=6 |pages=819–31 |year=1994 |month=September |pmid=7812190 }}</ref>

===Treatment===
Infection is treated and cured with [[metronidazole]] or [[tinidazole]]. Metronidazole would normally be prescribed for a 7 day period and Tinidazole as a two day course, which appears to have a higher success rate than the single dose option. Medication should be prescribed to any [[sexual partner]](s) as well because they may be [[asymptomatic carrier]]s.<ref name="Pmid" /><ref name=Cudmore_2004>{{cite journal |last1=Cudmore |first1=S. L. |last2=Delgaty |first2=K. L. |last3=Hayward-Mcclelland |first3=S. F. |last4=Petrin |first4=D. P. |last5=Garber |first5=G. E. |title=Treatment of Infections Caused by Metronidazole-Resistant ''Trichomonas vaginalis'' |journal=Clinical Microbiology Reviews |volume=17 |issue=4 |pages=783–93, table of contents |year=2004 |doi=10.1128/CMR.17.4.783-793.2004 |pmid=15489348 |pmc=523556}}</ref>

==Morphology==
The ''T. vaginalis'' [[trophozoite]] is oval as well as [[flagella]]ted, or "pear" shaped as seen on wet-mount slide. It is slightly larger than a white blood cell, measuring 9 X 7 μm. Five flagella arise near the cytostome; four of these immediately extend outside the cell together, while the fifth flagellum wraps backwards along the surface of the organism. The functionality of the fifth flagellum is not known. In addition, a conspicuous barb-like [[axostyle]] projects opposite the four-flagella bundle; the axostyle may be used for attachment to surfaces and may also cause the tissue damage noted in trichomoniasis infections.<ref name=Sherris>{{cite book |editor1-first=Kenneth James |editor1-last=Ryan |editor2-first=C. George |editor2-last=Ray |editor3-first=John C. |editor3-last=Sherris |title=Sherris Medical Microbiology |edition=4th | publisher=McGraw Hill |year=2004 |isbn=978-0-8385-8529-0}}{{page needed|date=January 2011}}</ref>

While ''T. vaginalis'' does not have a [[cyst]] form, organisms can survive for up to 24 hours in urine, semen, or even water samples. It has an ability to persist on [[fomite]]s with a moist surface for 1 to 2 hours.{{Citation needed|date=January 2012}}

==Protein function==
''T. vaginalis'' lacks mitochondria and therefore necessary enzymes and cytochromes to conduct [[oxidative phosphorylation]]. '' T. vaginalis'' obtains nutrients by transport through the [[cell membrane]] and by [[phagocytosis]]. The organism is able to maintain energy requirements by the use of a small amount of enzymes to provide energy via [[glycolysis]] of [[glucose]] to [[glycerol]] and [[succinate]] in the [[cytoplasm]], followed by further conversion of pyruvate and [[malate]] to hydrogen and acetate in an organelle called the [[hydrogenosome]].<ref name=Upcroft_2001>{{cite journal |last1=Upcroft |first1=P. |last2=Upcroft |first2=J. A. |title=Drug Targets and Mechanisms of Resistance in the Anaerobic Protozoa |journal=Clinical Microbiology Reviews |volume=14 |issue=1 |pages=150–64 |year=2001 |pmid=11148007 |pmc=88967 |doi=10.1128/CMR.14.1.150-164.2001}}</ref>

==Virulence factors==
One of the hallmark features of ''Trichomonas vaginalis'' is the adherence factors that allow cervicovaginal epithelium colonization in women. The adherence that this organism illustrates is specific to vaginal epithelial cells (VECs) being pH, time and temperature dependent. A variety of virulence factors mediate this process some of which are the microtubules, microfilaments, adhesins (4), and cysteine proteinases. The adhesins are four trichomonad enzymes called AP65, AP51, AP33, and AP23 that mediate the interaction of the parasite to the receptor molecules on VECs.<ref>{{cite journal |last1=Arroyo |first1=R. |last2=Engbring |first2=J. |last3=Alderete |first3=J. F. |title=Molecular basis of host epithelial cell recognition by ''Trichomonas vaginalis'' |journal=Molecular Microbiology |volume=6 |issue=7 |pages=853–862 |year=1992 |pmid=1602965 |doi=10.1111/j.1365-2958.1992.tb01536.x}}</ref> Cysteine proteinases may be another virulence factor because not only do these 30 kDa proteins bind to host cell surfaces but also may degrade extracellular matrix proteins like hemoglobin, fibronectin or collagen IV.<ref>{{cite journal |last1=Mendoza-Lopez |first1=M. R. |last2=Becerril-Garcia |first2=C. |last3=Fattel-Facenda |first3=L. V. |last4=Avila-Gonzalez |first4=L. |last5=Ruiz-Tachiquin |first5=M. E. |last6=Ortega-Lopez |first6=J. |last7=Arroyo |first7=R. |title=CP30, a Cysteine Proteinase Involved in ''Trichomonas vaginalis'' Cytoadherence |journal=Infection and Immunity |volume=68 |issue=9 |pages=4907–12 |year=2000 |pmid=10948104 |pmc=101697 |doi=10.1128/IAI.68.9.4907-4912.2000}}</ref>

==Genome sequencing and statistics==
The ''T. vaginalis'' genome was found to be approximately 160 [[megabase]]s in size<ref>{{cite journal |last1=Carlton |first1=J. M. |last2=Hirt |first2=R. P. |last3=Silva |first3=J. C. |last4=Delcher |first4=A. L. |last5=Schatz |first5=M. |last6=Zhao |first6=Q. |last7=Wortman |first7=J. R. |last8=Bidwell |first8=S. L. |last9=Alsmark |first9=U. C. M. |title=Draft Genome Sequence of the Sexually Transmitted Pathogen ''Trichomonas vaginalis'' |journal=Science |volume=315 |issue=5809 |pages=207–12 |year=2007 |pmid=17218520 |pmc=2080659 |doi=10.1126/science.1132894}}</ref> – ten times larger than predicted from earlier gel-based chromosome sizing <ref>{{cite journal |last1=Lehker |first1=M. W. |last2=Alderete |first2=J. F. |title=Resolution of Six Chromosomes of ''Trichomonas vaginalis'' and Conservation of Size and Number among Isolates |journal=The Journal of Parasitology |volume=85 |issue=5 |pages=976–9 |year=1999 |pmid=10577741 |jstor=3285842 |doi=10.2307/3285842}}</ref> (The human genome is ~3.5 [[gigabase]]s by comparison.<ref>{{cite journal |last1=Zimmer |first1=C. |title=EVOLUTION: Jurassic Genome |journal=Science |volume=315 |issue=5817 |pages=1358–9 |year=2007 |pmid=17347424 |doi=10.1126/science.315.5817.1358}}</ref>) As much as two-thirds of the ''T. vaginalis'' sequence consists of repetitive and [[transposable elements]], reflecting a massive, evolutionarily recent expansion of the genome. The total number of predicted protein-coding genes is ~98,000, which includes ~38,000 'repeat' genes (virus-like, transposon-like, [[retrotransposon]]-like, and unclassified repeats, all with high copy number and low [[Polymorphism (biology)|polymorphism]]). Approximately 26,000 of the protein-coding genes have been classed as 'evidence-supported' (similar either to known proteins, or to [[Expressed sequence tag|ESTs]]), while the remainder have no known function. These extraordinary genome statistics are likely to change downward as the genome sequence, currently very fragmented due to the difficulty of ordering repetitive DNA, is assembled into chromosomes, and as more transcription data (ESTs, [[DNA microarray|microarrays]]) accumulate. But it appears that the gene number of the single-celled parasite ''T. vaginalis'' is, at minimum, on par with that of its host ''H. sapiens''.

In late 2007 [http://www.trichdb.org TrichDB.org] was launched as a free, public genomic data repository and retrieval service devoted to genome-scale trichomonad data. The site currently contains all of the ''T. vaginalis'' sequence project data, several EST libraries, and tools for data mining and display. TrichDB is part of the NIH/NIAID-funded [http://www.Eupathdb.org EupathDB] functional genomics database project.<ref>{{cite journal |last1=Aurrecoechea |first1=Cristina |last2=Brestelli |first2=John |last3=Brunk |first3=Brian P. |last4=Carlton |first4=Jane M. |last5=Dommer |first5=Jennifer |last6=Fischer |first6=Steve |last7=Gajria |first7=Bindu |last8=Gao |first8=Xin |last9=Gingle |first9=Alan |title=GiardiaDB and TrichDB: integrated genomic resources for the eukaryotic protist pathogens ''Giardia lamblia'' and ''Trichomonas vaginalis'' |journal=Nucleic Acids Research |volume=37 |issue=Database issue |pages=D526–30 |year=2009 |pmid=18824479 |pmc=2686445 |doi=10.1093/nar/gkn631}}</ref>

==Increased susceptibility to HIV==
The damage caused by ''Trichomonas vaginalis'' to the vaginal endometrium increases a woman's susceptibility to an HIV infection. In addition to inflammation, the parasite also causes lysis of epithelial cells and RBCs in the area leading to more inflammation and disruption of the protective barrier usually provided by the epithelium. Having ''Trichomonas vaginalis'' also may increase the chances of the infected woman transmitting HIV to her sexual partner(s).<ref>{{cite journal |last1=Mulla |first1=Summaiyaa |last2=Kosambiya |first2=JK |last3=Desai |first3=Vikask |last4=Shethwala |first4=Nimishad |title=Sexually transmitted infections and reproductive tract infections in female sex workers |journal=Indian Journal of Pathology and Microbiology |volume=52 |issue=2 |pages=198–9 |year=2009 |pmid=19332911 |doi=10.4103/0377-4929.48916}}</ref><ref>{{cite journal |last1=Mavedzenge |first1=Sue Napierala |last2=Van der Pol |first2=Barbara |last3=Cheng |first3=Helen |last4=Montgomery |first4=Elizabeth T. |last5=Blanchard |first5=Kelly |last6=de Bruyn |first6=Guy |last7=Ramjee |first7=Gita |last8=Van der Straten |first8=Ariane |title=Epidemiological Synergy of ''Trichomonas vaginalis'' and HIV in Zimbabwean and South African Women |journal=Sexually Transmitted Diseases |volume=37 |issue=7 |pages=460–6 |year=2010 |pmid=20562586 |doi=10.1097/OLQ.0b013e3181cfcc4b}}</ref>

==See also==
* [[Alfred François Donné]]
* [[List of parasites (human)]]

==References==
<!-- ---------------------------------------------------------------
See http://en.wikipedia.org/wiki/Wikipedia:Footnotes for a
discussion of different citation methods and how to generate
footnotes using the <ref> & </ref> tags and the {{Reflist}} template
-------------------------------------------------------------------- -->
{{Reflist|2}}

==External links==
*TIGR's ''Trichomonas vaginalis'' [http://www.tigr.org/tdb/e2k1/tvg/ genome sequencing] project.
*[http://trichdb.org/trichdb/ TrichDB: the ''Trichomonas vaginalis'' genome sequencing project]
*NIH site on [http://www.nlm.nih.gov/medlineplus/ency/article/001331.htm trichomoniasis].
*[http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=5722 Taxonomy]
*[http://www.youngandhealthy.ca/caah/Informations/STI/t428c431s508x413/Trichomonas.aspx STI: What's trichomonas] a website for teenagers
*eMedicine article on [http://emedicine.medscape.com/article/787722-overview trichomoniasis].
*{{eol|2915544}}
*[http://www.patient.co.uk/health/Trichomonas-Infection.htm Patient UK]

{{Excavata}}
{{STD/STI}}
{{Protozoal diseases}}

{{DEFAULTSORT:Trichomonas Vaginalis}}
[[Category:Metamonads]]
[[Category:Sexually transmitted diseases and infections]]